

10 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260210380286/en/U.S.-Food-and-Drug-Administration-Accepts-New-Drug-Application-and-Grants-Priority-Review-for-Takedas-Oveporexton-TAK-861-as-a-Potential-First-in-Class-Therapy-for-Narcolepsy-Type-1